WEDELL-WEDELLSBORG JOHAN sold 20.2% of their position (168.24K shares) of Y-MABS THERAPEUTICS, INC. on the open market
Open‑market sale worth $4.64M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/22/2019ACC: 0001104659-19-046923
Director10% Owner
Since Sep 2018
-168.24K
Net shares
Net seller
$4.64M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
168.24K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−108.13K
Price / share
$27.42
Trade value
$2.96M
% of position
13.0%
8/20/2019
832.39K→724.26K
Common Stock
Indirect
Shares
−60.12K
Price / share
$27.83
Trade value
$1.67M
% of position
8.3%
8/21/2019
724.26K→664.15K
Total
Net shares
−168.24K
Net value
-$4.64M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/20/2019 | S · Sale | −108.13K | $27.42 | $2.96M | 13.0% | 832.39K | 724.26K |
| Common Stock Indirect | 8/21/2019 | S · Sale | −60.12K | $27.83 | $1.67M | 8.3% | 724.26K | 664.15K |
| Total | −168.24K | -$4.64M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned5.01M
Total
5.01M indirect5.01M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 5.01M | Indirect |
| Total | 5.01M | 5.01M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported